Novo Nordisk A/S
NVO
$44.96
$0.571.28%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 25.03% | 5.48% | 10.95% | 24.06% | 15.82% |
| Total Depreciation and Amortization | 52.69% | 79.38% | 97.22% | 64.58% | 29.49% |
| Total Amortization of Deferred Charges | 36.01% | 36.01% | 18.52% | 18.52% | 18.52% |
| Total Other Non-Cash Items | -124.81% | -136.08% | -70.45% | -54.76% | 119.93% |
| Change in Net Operating Assets | -323.63% | 207.81% | 91.12% | -804.06% | 74.63% |
| Cash from Operations | -3.60% | 2.91% | 8.49% | 7.05% | 39.45% |
| Capital Expenditure | -19.80% | -33.66% | -45.36% | -65.74% | -74.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -196.95% | -- | -- |
| Cash Acquisitions | 101.33% | 101.33% | -11,983.50% | -11,983.50% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -490.96% | -7,376.51% | 206.58% | 151.27% | -33.42% |
| Cash from Investing | 34.57% | 34.71% | -142.29% | -195.45% | -312.28% |
| Total Debt Issued | -13.31% | 30.91% | 240.93% | 240.38% | -- |
| Total Debt Repaid | -278.88% | -1,150.01% | -1,154.08% | -1,200.60% | -1,282.08% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 87.19% | 93.12% | 60.45% | 56.91% | 32.03% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -10.45% | -17.53% | -17.53% | -18.84% | -18.84% |
| Other Financing Activities | -203.04% | -- | -- | -- | 965.68% |
| Cash from Financing | -238.90% | -499.27% | 32.31% | 33.89% | 155.90% |
| Foreign Exchange rate Adjustments | -408.53% | -271.16% | 66.65% | -294.17% | 62.40% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -156.93% | 491.38% | -192.12% | -213.65% | 482.86% |